TempoGene
Supports its commercial services by contemporary expertise and long standing experience in these fields and by employing next generation sequencing technology and bioinformatics to advance breeding and productivity and to safeguard food and beverages.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
NOK1.5m | Debt | ||
| Total Funding | 000k | ||
| EUR | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | 254 % | (75 %) | (4 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | (399 %) | (178 %) | - | (1760 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | (294 %) | (141 %) | (1041 %) | (1384 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Tempogene is a pioneering company specializing in genetic solutions for the aquaculture and food safety sectors. The company serves clients ranging from aquaculture farms to food safety regulators, providing them with cutting-edge molecular diagnostics and bioinformatics services. Operating in the biotechnology market, Tempogene employs a business model that focuses on offering specialized genetic testing and analysis services. Revenue is generated through service contracts, consulting fees, and long-term partnerships with industry stakeholders. The company's core competencies include advanced genetic analysis, high-resolution mapping, and genomic selection, which are crucial for improving aquaculture productivity and ensuring food safety.
Keywords: genetic solutions, aquaculture, food safety, molecular diagnostics, bioinformatics, genetic testing, biotechnology, genomic selection, high-resolution mapping, industry partnerships.